financetom
Business
financetom
/
Business
/
SAP To Acquire Reltio To Power Next Wave Of Enterprise AI
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SAP To Acquire Reltio To Power Next Wave Of Enterprise AI
Mar 27, 2026 9:56 AM

SAP SE ( SAP ) shares fell on Friday after the company announced plans to acquire Reltio Inc. The move aims to strengthen its data capabilities and expand enterprise AI use cases.

Deal Overview And Strategic Impact

SAP said the deal is expected to close in the second or third quarter of 2026, pending regulatory approvals. The company did not disclose financial terms.

The acquisition will enhance SAP's Business Data Cloud platform. It will help customers unify and harmonize data across SAP and non-SAP systems. As a result, businesses can better support enterprise-wide agentic AI.

Reltio will also remain available as a standalone product while becoming a core part of SAP BDC.

Reltio Platform And Financial Position

Reltio's platform creates a single "golden record" by combining data from multiple sources. This improves data quality, consistency, and reliability for AI-driven insights.

In addition, the platform supports real-time, multi-agent workflows. It also offers industry-specific solutions that reduce data fragmentation and improve decision-making.

"Reltio is a natural fit with SAP," said Muhammad Alam, member of the Executive Board of SAP SE ( SAP ), SAP Product & Engineering.

"Acquiring them will further improve our position as a leading business AI provider, combining SAP and non-SAP data to deliver data context that business AI requires. AI cannot reach its full potential when data is fragmented across business units, platforms and domains without connection or context."

SAP reported cash and cash equivalents of 8.33 billion euros (about $9.61 billion) as of Dec. 31, 2025.

SAP Price Action

SAP shares were down 1.42% at $164.70 at the time of publication on Friday. The stock is trading at a new 52-week low, according to Benzinga Pro data.

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vera Therapeutics Q3 EPS misses estimates
Vera Therapeutics Q3 EPS misses estimates
Nov 5, 2025
Overview * Vera Therapeutics ( VERA ) Q3 net loss and EPS miss analyst expectations * Company expects BLA submission for atacicept in Q4 2025 * Vera maintains strong cash position, funding operations through potential atacicept launch Outlook * Company expects to submit BLA for atacicept to FDA in Q4 2025 * Vera anticipates potential U.S. launch of atacicept in...
Charles River raises annual profit forecast on stabilizing biotech demand
Charles River raises annual profit forecast on stabilizing biotech demand
Nov 5, 2025
Nov 5 (Reuters) - Contract drug developer Charles River Laboratories ( CRL ) on Wednesday raised its annual profit forecast after posting strong third-quarter results, helped by stabilized demand for its drug discovery and development services from biotech clients. Demand for our extensive portfolio of early-stage research and manufacturing products and services remains stable, said CEO James Foster. We believe...
Royalty Pharma's Q3 Net Income Falls, Revenue Rises
Royalty Pharma's Q3 Net Income Falls, Revenue Rises
Nov 5, 2025
07:33 AM EST, 11/05/2025 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Q3 net income Wednesday of $288 million, compared with $544 million a year earlier. Analyst estimates were not readily available for comparison. Total income and other revenue for the quarter ended Sept. 30 was $609 million, compared with $565 million a year earlier. ...
Parsons Q3 Adjusted Earnings, Revenue Fall; 2025 Revenue Outlook Lowered
Parsons Q3 Adjusted Earnings, Revenue Fall; 2025 Revenue Outlook Lowered
Nov 5, 2025
07:35 AM EST, 11/05/2025 (MT Newswires) -- Parsons (PSN) reported Q3 adjusted earnings Wednesday of $0.86 per diluted share, down from $0.95 a year earlier. Analysts polled by FactSet expected $0.74. Revenue for the quarter ended Sept. 30 was $1.62 billion, down from $1.81 billion a year earlier. Analysts surveyed by FactSet expected $1.66 billion. The company said it now...
Copyright 2023-2026 - www.financetom.com All Rights Reserved